Clinical TrialsSearch results
Number of results: 596
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Completed
- A study on the safety and utility of a novel Mitochondrial Function PET tracer [18F]BCPP-BF
- Whole body search
- Bunai Tomoyasu
- 2022-07-13
Not yet recruiting
- The effect on VR sickness of a VR locomotion chair.
- VR sickness
- Hoshi Yoko
- 2024-10-08
Other
- Refractory VT/VF, Prospective Evaluation to Differentiate Lidocaine Efficacy from Nifekalant
- Ventricular tachycardia, Ventricular fibrillation
- Japan Medical Promotion Agency
- 2009-03-18
Other
- Clinical study of Prevention and Actual situation of Venous Thromboembolism after Total Arthroplasty
- Venous Thromboembolism Osteoarthrosis
- National Hospital Organization
- 2008-09-11
Other
- Gemcitabine Plus Paclitaxel versus Gemcitabine alone in Patients with Recurrent or Advanced Urothelial Cancer previously Treated With Cisplatin-based Chemotherapy: A randomized Phase II study
- Urothelial cancer
- Teikyo University
- 2009-10-01
Recruiting
- Optimal Conditions in Diffusion-Weighted Imaging
- Upper abdominal malignancy
- Ozaki Kumi
- 2024-11-19
Other
- Quantification of Epstein-Barr virus DNA in patients undergoing SMILE chemotherapy for stage IV or relapsed/refractory extranodal NK/T-cell lymphoma
- untreated stage IV or relapsed/refractory NK/T-cell lymphoma
- NK-cell Tumor Study Group
- 2007-06-18
Recruiting
- A study to compare efficacy, safety, and immunogenicity of GME751 and EU-authorized Keytruda in adult participants with untreated metastatic non-squamous non-small cell lung cancer (NSCLC)
- Untreated metastatic non-squamous non-small cell lung cancer (NSCLC)
- Strewe Claudia
- 2024-04-23
Other
- Hypertension Objective Treatment Based on Measurement by Electrical Devices of Blood Pressure (HOMED-BP) Study: Prospective Randomized Open-label Blinded Endpoint (PROBE)
- Untreated essential hypertensive patients
- HOMED-BP Study Group
- 2005-09-09
Other
- A multicenter, observational study for reactivation of hepatitis B virus by means of serial HBV-DNA monitoring during and just after systemic chemotherapy containing rituximab plus steroid for malignant lymphoma (C-SHOT 0802)
- Untreated CD20-positive, B-cell non-Hodgkin's lymphoma in the patients with seronegativity for HBsAg and seropositivity for HBc-Ab and/or HBs-Ab, which is planned to be treated with 6-8 courses of systemic chemotherapy containing rituximab plus steroid such as R-CHOP, R-CVP, R-THP-COP and R-C-MOPP
- Nagoya City University Hospital
- 2008-08-11